(Q37736461)

English

Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice

scientific article published on May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

1 reference

Europe PubMed Central

Real-world clinical effectiveness, regulatory transparency and payer coverage: three ingredients for translating pharmacogenomics into clinical practice (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

pharmacogenomics

1 reference

based on heuristic

inferred from title

author name string

Felix W Frueh

1

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Pharmacogenomics

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

657-660

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.46

21 January 2018

Translation of pharmacogenomics and pharmacogenetics: a regulatory perspective

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.46

21 January 2018

Three years of promise, proposals, and progress on optimizing the benefit/risk of medicines: a commentary on the 3rd FDA-DIA-PWG-PhRMA-BIO pharmacogenomics workshop

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.46

21 January 2018

Health spending growth at a historic low in 2008.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.46

21 January 2018

Payer perspectives on pharmacogenomics testing and drug development.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.46

21 January 2018

Economic opportunities and challenges for pharmacogenomics

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.46

21 January 2018

Identifiers

10.2217/PGS.10.46

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37736461&oldid=1726387646"